{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:53:06Z","timestamp":1780541586467,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.antiviral.2014.03.011","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T17:09:04Z","timestamp":1395940144000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening"],"prefix":"10.1016","volume":"106","author":[{"given":"Michael K.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.03.011_b0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jviromet.2008.01.016","article-title":"Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus","volume":"149","author":"Aljofan","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2014.03.011_b0010","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI105025","article-title":"The effect of 6-azauridine administration on De Novo pyrimidine production in chronic myelogenous leukemia","volume":"43","author":"Bono","year":"1964","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2014.03.011_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1743-422X-2-57","article-title":"Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein","volume":"2","author":"Bossart","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.03.011_b0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.antiviral.2013.06.012","article-title":"A treatment for and vaccine against the deadly Hendra and Nipah viruses","volume":"100","author":"Broder","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.03.011_b0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-7-115","article-title":"Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA","volume":"7","author":"Chiang","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.03.011_b0035","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/protein\/12.12.1035","article-title":"Attenuation of green fluorescent protein half-life in mammalian cells","volume":"12","author":"Corish","year":"1999","journal-title":"Protein Eng."},{"key":"10.1016\/j.antiviral.2014.03.011_b0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/infdis\/jis653","article-title":"Type I interferon signaling protects mice from lethal henipavirus infection","volume":"207","author":"Dhondt","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.03.011_b0045","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/JVI.02576-12","article-title":"Henipavirus pathogenesis in human respiratory epithelial cells","volume":"87","author":"Escaffre","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2007.08.008","article-title":"Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA","volume":"370","author":"Freiberg","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.03.011_b0055","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.50.5.1768-1772.2006","article-title":"Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection","volume":"50","author":"Georges-Courbot","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.03.011_b0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1749-6632.1975.tb29257.x","article-title":"Biochemistry and biological effects of the pyrazofurins (pyrazomycins): initial clinical trial","volume":"255","author":"Gutowski","year":"1975","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2014.03.011_b0065","doi-asserted-by":"crossref","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.03.011_b0070","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.72.2.891-899.1998","article-title":"Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited","volume":"72","author":"Kolakofsky","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0075","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1128\/JVI.02599-08","article-title":"Nipah virus edits its P gene at high frequency to express the V and W proteins","volume":"83","author":"Kulkarni","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0080","doi-asserted-by":"crossref","first-page":"e47790","DOI":"10.1371\/journal.pone.0047790","article-title":"Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response","volume":"7","author":"Lo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.03.011_b0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/protein\/gzl023","article-title":"Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output","volume":"19","author":"Loening","year":"2006","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.antiviral.2014.03.011_b0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2013.07.011","article-title":"The pandemic potential of Nipah virus","volume":"100","author":"Luby","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.03.011_b0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1743-422X-10-95","article-title":"Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets","volume":"10","author":"Marsh","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.03.011_b0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/heapro\/das020","article-title":"Piloting the use of indigenous methods to prevent Nipah virus infection by interrupting bats\u2019 access to date palm sap in Bangladesh","volume":"28","author":"Nahar","year":"2013","journal-title":"Health Promot. Int."},{"key":"10.1016\/j.antiviral.2014.03.011_b0105","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1128\/JVI.00164-09","article-title":"Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy","volume":"83","author":"Porotto","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0110","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1128\/JVI.76.22.11476-11483.2002","article-title":"Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation","volume":"76","author":"Rodriguez","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0115","first-page":"41","article-title":"Molecular virology of the henipaviruses","volume":"359","author":"Rota","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0120","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1128\/JVI.79.10.6078-6088.2005","article-title":"Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways","volume":"79","author":"Shaw","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0125","doi-asserted-by":"crossref","first-page":"e30538","DOI":"10.1371\/journal.pone.0030538","article-title":"Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment","volume":"7","author":"Talekar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.03.011_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2009.02.025","article-title":"Development of a neutralization assay for Nipah virus using pseudotype particles","volume":"160","author":"Tamin","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2014.03.011_b0135","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1128\/JVI.02412-10","article-title":"Interferon signaling remains functional during henipavirus infection of human cell lines","volume":"85","author":"Virtue","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0140","doi-asserted-by":"crossref","first-page":"e1001186","DOI":"10.1371\/journal.ppat.1001186","article-title":"Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.03.011_b0145","doi-asserted-by":"crossref","first-page":"11076","DOI":"10.1128\/JVI.01425-13","article-title":"Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response","volume":"87","author":"Yan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.011_b0150","doi-asserted-by":"crossref","first-page":"16508","DOI":"10.1073\/pnas.0606972103","article-title":"Establishment of a Nipah virus rescue system","volume":"103","author":"Yoneda","year":"2006","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.03.011_b0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T22:41:31Z","timestamp":1597617691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"alternative-id":["S0166354214000850"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.03.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}